183 related articles for article (PubMed ID: 34365471)
21. Male breast cancer: an update.
Fox S; Speirs V; Shaaban AM
Virchows Arch; 2022 Jan; 480(1):85-93. PubMed ID: 34458944
[TBL] [Abstract][Full Text] [Related]
22. Severe hypoglycemia and finger clubbing in a patient with a BRCA1 mutation in a solitary fibrous tumor: a case report.
Guo W; Ji Y; Guo L; Che S; Huai Q; Yang K; Tan F; Xue Q; Gao S; He J
Ann Transl Med; 2021 Jul; 9(13):1093. PubMed ID: 34423005
[TBL] [Abstract][Full Text] [Related]
23. BRCA1 Antibodies Matter.
Yang J; Qi L; Chiang HC; Yuan B; Li R; Hu Y
Int J Biol Sci; 2021; 17(12):3239-3254. PubMed ID: 34421362
[No Abstract] [Full Text] [Related]
24. Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.
Ruiz de Garibay G; Fernandez-Garcia I; Mazoyer S; Leme de Calais F; Ameri P; Vijayakumar S; Martinez-Ruiz H; Damiola F; Barjhoux L; Thomassen M; Andersen LVB; Herranz C; Mateo F; Palomero L; Espín R; Gómez A; García N; Jimenez D; Bonifaci N; Extremera AI; Castaño J; Raya A; Eyras E; Puente XS; Brunet J; Lázaro C; ; ; Radice P; Barnes DR; Antoniou AC; Spurdle AB; de la Hoya M; Baralle D; Barcellos-Hoff MH; Pujana MA
Hum Mutat; 2021 Nov; 42(11):1488-1502. PubMed ID: 34420246
[TBL] [Abstract][Full Text] [Related]
25. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer.
Brett JO; Spring LM; Bardia A; Wander SA
Breast Cancer Res; 2021 Aug; 23(1):85. PubMed ID: 34392831
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism incidence in cancer patients with germline BRCA mutations.
Muñoz AJ; de Toro M; Ortega L; López C; Gutiérrez A; Juliao DS; Arregui M; Lobato N; Echavarría I; Márquez-Rodas I; Martín M
Clin Transl Oncol; 2022 Jan; 24(1):154-158. PubMed ID: 34374030
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer: a multi-center retrospective analysis.
Zhang L; Song G; Shao B; Xu L; Xiao Y; Wang M; Sumou IK; Zhang Y; Liang X; Jiang H; Li H
Anticancer Drugs; 2022 Jan; 33(1):e635-e643. PubMed ID: 34371506
[TBL] [Abstract][Full Text] [Related]
28. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge.
Bono M; Fanale D; Incorvaia L; Cancelliere D; Fiorino A; Calò V; Dimino A; Filorizzo C; Corsini LR; Brando C; Madonia G; Cucinella A; Scalia R; Barraco N; Guadagni F; Pedone E; Badalamenti G; Russo A; Bazan V
ESMO Open; 2021 Aug; 6(4):100235. PubMed ID: 34371384
[TBL] [Abstract][Full Text] [Related]
29. Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
Conteduca V; Scarpi E; Farolfi A; Brighi N; Rossi L; Gurioli G; Lolli C; Schepisi G; Bleve S; Gianni C; Virga A; Altavilla A; Burgio SL; Menna C; De Giorgi U
Front Oncol; 2021; 11():716467. PubMed ID: 34367999
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells.
Gajan A; Sarma A; Kim S; Gurdziel K; Wu GS; Shekhar MP
Front Oncol; 2021; 11():694793. PubMed ID: 34367977
[TBL] [Abstract][Full Text] [Related]
31. BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
Maccaroni E; Giampieri R; Lenci E; Scortichini L; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Ambrosini E; Berardi R
World J Clin Oncol; 2021 Jul; 12(7):565-580. PubMed ID: 34367929
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors.
Imyanitov E; Sokolenko A
World J Clin Oncol; 2021 Jul; 12(7):544-556. PubMed ID: 34367927
[TBL] [Abstract][Full Text] [Related]
33. Development of an AI system for accurately diagnose hepatocellular carcinoma from computed tomography imaging data.
Wang M; Fu F; Zheng B; Bai Y; Wu Q; Wu J; Sun L; Liu Q; Liu M; Yang Y; Shen H; Kong D; Ma X; You P; Li X; Tian F
Br J Cancer; 2021 Oct; 125(8):1111-1121. PubMed ID: 34365472
[TBL] [Abstract][Full Text] [Related]
34. Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.
Aziz D; Portman N; Fernandez KJ; Lee C; Alexandrou S; Llop-Guevara A; Phan Z; Yong A; Wilkinson A; Sergio CM; Ferraro D; Etemadmoghadam D; Bowtell DD; ; Serra V; Waring P; Lim E; Caldon CE
NPJ Breast Cancer; 2021 Aug; 7(1):111. PubMed ID: 34465787
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia with cup-like blasts and FLT3-ITD and NPM1 mutations mimics features of acute promyelocytic leukemia: a case of durable remission after sorafenib and low-dose cytarabine.
Sun J; Ning S; Feng R; Li J; Wang T; Xing B; Zhu X; Zhao Y; Pei L; Liu H
Anticancer Drugs; 2022 Jan; 33(1):e813-e817. PubMed ID: 34459465
[TBL] [Abstract][Full Text] [Related]
36. Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies.
Kanwal B
Cureus; 2021 Jul; 13(7):e16636. PubMed ID: 34458041
[TBL] [Abstract][Full Text] [Related]
37. Identification of
Hamdi Y; Boujemaa M; Mighri N; Mejri N; Jaidane O; Ben Nasr S; Bouaziz H; Hassouna JB; Zribi A; Berrazaga Y; Rachdi H; Daoud N; El Benna H; Labidi S; Haddaoui A; Rahal K; Benna F; Boussen H; Abdelhak S; Boubaker S
Front Genet; 2021; 12():674990. PubMed ID: 34456966
[No Abstract] [Full Text] [Related]
38. Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Steenbeek MP; van Bommel MHD; Harmsen MG; Hoogerbrugge N; van Doorn HC; Keurentjes JHM; van Beurden M; Zweemer RP; Gaarenstroom KN; Penders CGJ; Brood-van Zanten MMA; Vos MC; Piek JM; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; IntHout J; de Hullu JA; Hermens RPMG
Gynecol Oncol; 2021 Nov; 163(2):371-377. PubMed ID: 34456057
[TBL] [Abstract][Full Text] [Related]
39. Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant.
Brédart A; De Pauw A; Anota A; Tüchler A; Dick J; Müller A; Kop JL; Rhiem K; Schmutzler R; Devilee P; Stoppa-Lyonnet D; Dolbeault S
Breast; 2021 Dec; 60():38-44. PubMed ID: 34455229
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
